Drug efficacy analysis overall interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen

Preferred Label : Drug efficacy analysis overall interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen;

LOINC status : ACTIVE;

LOINC display name : Drug efficacy analysis overall interpretation Molgen (Bld/Tiss) [Interp];

LOINC long common name : Drug efficacy analysis overall interpretation;

LOINC short name : Drug eff analysis imp-Imp;

LOINC description : Overall predicted phenotype for drug efficacy for all markers and/or individual alleles identified in a single case.;

Détails

Origin ID

51964-5;

UMLS CUI

C2360733;

Has component
- Drug [LOINC component]
- Drug efficacy analysis overall interpretation [LOINC component]
- Interpretation [LOINC component]
- Overall [LOINC component]
Has method
- Molecular genetics [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Genetic analysis summary panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
- Pharmacogenetic DNA analysis panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
- Pharmacogenomic analysis basic associated observations panel:-:Pt:Bld/Tiss:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients